Are neurologists really data driven in selecting epilepsy treatment?

David M. Labiner; Gregory D. Cascino

doi:10.1212/WNL.0b013e318250d86b

Are neurologists really data driven in selecting epilepsy treatment?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1194-1195
Number of pages	2
Journal	Neurology
Volume	78
Issue number	16
DOIs	https://doi.org/10.1212/WNL.0b013e318250d86b
State	Published - Apr 17 2012

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e318250d86b

Cite this

@article{44edd2eaf23c47e79fabcd1d304ffa49,

title = "Are neurologists really data driven in selecting epilepsy treatment?",

author = "Labiner, {David M.} and Cascino, {Gregory D.}",

note = "Funding Information: Dr. Labiner has received speaker honoraria from Cyberonics, Inc.; serves on speakers' bureaus for Cyberonics, Inc., Eisai Inc., Pfizer Inc., and UCB; has received research support from GlaxoSmithKline, UCB, Ikano Therapeutics Inc., Johnson & Johnson, Eisai, Inc., Janssen, King Pharmaceuticals, the US Centers for Disease Control and Prevention, and the NIH; and serves on the Board of Directors of the Epilepsy Foundation and the Epilepsy Foundation of Arizona. Dr. Cascino serves as an Associate Editor for Neurology{\textregistered} and receives research support from NeuroPace Inc. and the NIH.",

year = "2012",

month = apr,

day = "17",

doi = "10.1212/WNL.0b013e318250d86b",

language = "English (US)",

volume = "78",

pages = "1194--1195",

journal = "Neurology",

issn = "0028-3878",